The cell lysis industry is growing rapidly and is expected to continue growing in the foreseeable future. According to a recent study, the global Cell Lysis Market size is projected to reach 4.1 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 7.2% during the forecast period. The rising demand for cell fractionation techniques for the diagnosis of diseases such as cancer, cardiovascular disorders, and neurological diseases is expected to drive the market. The rise in the number of clinical trials and research activities involving the use of cell fractionation techniques is anticipated to drive the growth of the market. The growing demand for biologics and personalized medicines is expected to contribute to the market growth. The increasing penetration of cell fractionation in the fields of biopharmaceuticals, proteomics, and genomics is expected to fuel the growth of the market. The increasing number of mergers and acquisitions and collaborations among key players is projected to drive the market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260138321
Innovation in Cell Lysis Market
The cell lysis market is highly competitive and is constantly developing new technologies to improve the speed, accuracy, and efficiency of cell lysis. Innovations in the cell lysis market include the development of novel lysis agents, such as detergents, enzymes, and chaotropic agents, that can effectively lyse cells. Additionally, new methods of cell lysis, such as sonication, laser microdissection, and mechano-chemical lysis, are being developed to improve the speed and accuracy of the lysis process. Furthermore, advancements in automation and miniaturization of cell lysis techniques have made them more accessible and cost-effective. Finally, microfluidic devices are being developed to enable the lysis of cells in small volumes, allowing more efficient sample processing.
Some of the prominent key players are:
- Thermo Fisher Scientific (US),
- Merck KGaA (Germany),
- Becton, Dickinson and Company (US),
- Danaher Corporation (US),
- Bio-Rad Laboratories (US),
- Cell Signaling Technology Inc. (US),
- Miltenyi Biotec (Germany) and many more…….
Thermo Fisher Scientific (US)
Thermo Fisher Scientifc (US) held the leading position in the cell lysis market in 2020. Thermo Fisher offers an exhaustive product portfolio consisting of various cell lysis products, such as reagents, kits, and media. The company believes in both organic and inorganic growth for enhancing its market position such collaboration, acquisition and expansion. For instance, in 2020, Thermo Fisher Scientific entered collaboration with Northeastern University To advance analytical capabilities and accelerate innovation across the biopharmaceutical industry in personalized medicine, monoclonal antibodies, and gene and cell therapies. Furthermore, the company is innovation-centric and invests heavily in R&D to maintain its market share..
Merck (Germany)
Merck (Germany) accounted for the second-largest share of the global cell lysis market in 2020. The company provides its radiation dowing to its robust portfolio of cell lysis products and efforts to develop innovative products by investing in R&D. To sustain its leading position in the cell lysis market, the company pursues organic and inorganic strategies such as expansion. For instance, in 2020, the company expanded Life Science production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire, US
Recent Developments
- In 2020, Thermo Fisher Scientific entered into collaboration with Northeastern University To advance analytical capabilities and accelerate innovation across the biopharmaceutical industry in personalized medicine, monoclonal antibodies, and gene & cell therapies
- In 2020, Danaher Corporation acquired biopharma business from GE Company’s life science segment.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=260138321
The cell lysis market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest share of the cell lysis market. The large share of North America can be attributed to factors such as the Growing stem cell and cancer research activities and the expanding biotechnology & pharmaceutical industries
